Changing the World at the Molecular Level
A patient's healthcare story is siloed, disjointed and inaccessible. Abridge started as a collaboration between the University of Pittsburgh Medical Center (UPMC) and Carnegie Mellon University (CMU) to build speech, voice, and language technologies to better capture our healthcare stories and empower the patient and unburden practitioners.
Dyno Therapeutics creates novel adeno-associated virus (AAV) vectors that enable safe, efficient and targeted in vivo delivery for revolutionary new gene therapies. Dyno is systematically mapping the relationship between capsid sequence and function and optimizing AAV for improved therapeutic efficacy.